Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2025-12-24 @ 10:51 PM
NCT ID:
NCT06585969
Eligibility Criteria:
Inclusion Criteria:
* Women aged 18 or above.
* Radiologically/pathologically verified metastatic breast cancer.
* ER-positive (1% or more) and HER2-low (HER2 1+ or HER2 2+/ISH-neg)10,11.
* PAM50 Luminal B, HER2-enriched or Basal-like.
* Performance status 0-1.
* Evaluable disease
Exclusion Criteria:
* Patients who are incapable of understanding the written material received
* Patients with inaccessible tumour tissue
* Other malignant disease within 5 years (in situ cervix and non-melanoma skin cancer excluded)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT06585969
Study Brief:
Protocol Section:
NCT06585969